Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Drug Dependence

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...

Drug Abuse and Addiction: Pharmacological Phenomena

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...

Drug Toxicity: Dose-Dependent Reactions

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

Drug Dosing: Infants and Children

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Parent's hesitance about HPV Vaccine: Using the CASE approach to address their concerns.

Minnesota medicine·2021

Same journal

Vaping, lung injury, and mental health Minnesota 2018-2019.

Minnesota medicine·2021

Same journal

Characteristics of clinical extrapulmonary nontuberculous mycobacteria isolates in Minnesota, 2013-2017.

Minnesota medicine·2020

Same journal

Challenges for younger adults with diabetes.

Minnesota medicine·2020

Same journal

Telemedicine in Minnesota: A look at how four specialties are using it.

Minnesota medicine·2019

Same journal

The Doctor Will See You On Screen: Telemedicine offers convenient access to care, cost savings and the same quality as in-person visits-sometimes.

Minnesota medicine·2019

Search research articles

Related Experiment Video

Updated: May 9, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Neonatal drug withdrawal.

Jane E Barthell¹, Jeanne D Mrozek

¹Children's Hospital and Clinics of Minnesota, Minneapolis Campus, USA.

Minnesota Medicine

|August 13, 2013

Summary

The number of babies born with drug addiction is rising due to increased prenatal drug exposure. This article outlines neonatal drug withdrawal symptoms and proposes prevention and treatment strategies.

Area of Science:

Neonatal Abstinence Syndrome (NAS) research
Maternal-fetal medicine
Pediatric pharmacology

Background:

Increasing prevalence of prenatal exposure to both illicit and prescribed substances.
Growing incidence of neonatal drug withdrawal and addiction in newborns.
Need for standardized diagnostic and management protocols.

Observation:

Identification of key clinical signs and symptoms indicative of neonatal drug withdrawal.
Correlation between maternal substance use during pregnancy and infant outcomes.
Variability in withdrawal severity based on substance type and duration of exposure.

Findings:

Detailed description of neonatal drug withdrawal manifestations.
Discussion of non-pharmacological and pharmacological treatment options.

More Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

Neurodevelopmental Reflex Testing in Neonatal Rat Pups

Neurodevelopmental Reflex Testing in Neonatal Rat Pups

Published on: April 24, 2017

Related Experiment Videos

Last Updated: May 9, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

Neurodevelopmental Reflex Testing in Neonatal Rat Pups

Neurodevelopmental Reflex Testing in Neonatal Rat Pups

Published on: April 24, 2017

Emphasis on a multidisciplinary approach involving neonatologists, nurses, and social workers.

Implications:

Improved early detection and management of neonatal drug withdrawal.
Enhanced support for affected infants and their families.
Potential reduction in long-term health complications associated with NAS.